The Laboratory tubes

Product

Eyeseryl 820959-17-9 Improve the under-eye region

Short Description:

Product name: Eyeseryl
Synonyms: Acetyl tetrapeptide-5, eye serine peptide
INCI name: Acetyl tetrapeptide-5
CAS No.: 820959-17-9
Sequence: Ac-Beta-Ala-His-Ser-His-OH
Quality: purity 98% up by HPLC
Molecular formula: C20H28N8O7
Molecular weight: 492.49


Product Detail

Product Tags

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Order(MOQ): 1g
Lead Time: 3 Working Days
Production capacity: 40kg/month
Storage condition: with ice bag for transportation, 2-8℃ for long term storage
Package material: vial, bottle
Package size:1g/vial, 5/vial, 10g/vial, 50g/bottle, 500g/bottle

Eyeseryl

Introduction

EYESERYL peptide helps improve the overall appearance of the eye contour by minimising the presence of eyebags and dark circles and by reducing skin damage of this delicate area.

The ability of the peptide to minimise the eyebags volume was recently assessed in a new study performed on male volunteers between 30-65 years old with prominent eyebags that applied a cream containing 1% EYESERYL peptide solution on one eye contour and a placebo cream on the other, twice a day for 28 days.

Under-eye puffiness volume significantly decreased up to 29.7% after 28 days, and the overall appearance of the eye contour visibly improved as observed through digital photographs.

In addition, on the self-evaluation of the subjects, 90% of the volunteers positively rated the treatment, willing to recommend the product as an efficient anti-eyebags treatment.

Sign up for your free email newsletter
EYESERYL peptide helps improve the under-eye region in men and women, being an ideal product to incorporate into eye contour formulations intended to minimise the appearance of fluid and fat-related eyebags as well as to reduce under-eye dark circles and tissue damage.

Specification (purity 98% up by HPLC)

TEST SPECIFICATION
Appearance White or pale yellow powder
MS 492.5±1
Purity (by HPLC) ≥90.0%

  • Previous:
  • Next: